Is Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)’s Fuel Running Low? Reports Show More Sellers

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Logo

The stock of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) registered an increase of 30.83% in short interest. ZYNE’s total short interest was 3.01 million shares in April as published by FINRA. Its up 30.83% from 2.30 million shares, reported previously. With 1.42M shares average volume, it will take short sellers 2 days to cover their ZYNE’s short positions. The short interest to Zynerba Pharmaceuticals Inc’s float is 19.47%.

The stock decreased 0.42% or $0.04 during the last trading session, reaching $9.97. About 638,688 shares traded. Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) has declined 47.62% since April 25, 2018 and is downtrending. It has underperformed by 51.99% the SP500.

Zynerba Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company has market cap of $210.03 million. The Company’s product

... read more at: